Jedzada Maneechavakajorn

Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

Joseph Gligorov, Beyhan Ataseven, Mark Verrill et al. · European Journal of Cancer · 2017 · 46 citations

Breast Oncology, Medicine, Primary Analysis +7

A randomized, double-blind, placebo-controlled study evaluating the efficacy of combination olanzapine, ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving doxorubicin plus cyclophosphamide

Piyawan Tienchaiananda, Wipada Nipondhkit, Kunlatida Maneenil et al. · Annals of Palliative Medicine · 2019 · 39 citations · Full text

Quality of life, Functional Assessment of Cancer Therapy-General.

Vorachai Ratanatharathorn, Suwannee Sirilerttrakul, Manmana Jirajarus et al. · PubMed · 2001 · 38 citations

Quality Of Life, Life Assessment, Cancer Management +16

Prognostic factors for survival in colorectal cancer patients.

Sudsawat Laohavinij, Jedzada Maneechavakajorn, Parapat Techatanol · PubMed · 2010 · 37 citations

Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine

Gerald Goh, Ramona Schmid, Kelly Guiver et al. · PLoS Medicine · 2016 · 36 citations · Full text